Regulus Therapeutics Inc. 4
4 · Regulus Therapeutics Inc. · Filed Feb 23, 2017
Insider Transaction Report
Form 4
WRIGHT TIMOTHY MICHAEL
Chief R & D Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-02-15+32,412→ 32,412 totalExercise: $1.20Exp: 2027-02-14→ Common Stock (32,412 underlying)
Footnotes (1)
- [F1]25% of the shares vest on January 1, 2018 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on January 1, 2021.